Cargando…

Immunotherapy in non-metastatic non-small cell lung cancer: Can the benefits of stage IV therapy be translated into earlier stages?

Over the last decade, several steps forward in the treatment of patients with stage IV non-small cell lung cancer (NCSLC) were made. Examples are the use of pemetrexed, pemetrexed maintenance therapy, or bevacizumab for patients with nonsquamous NSCLC. A big leap forward was the use of tyrosine kina...

Descripción completa

Detalles Bibliográficos
Autores principales:	Deslypere, Griet, Gullentops, Dorothée, Wauters, Els, Vansteenkiste, Johan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2018
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5949924/ https://www.ncbi.nlm.nih.gov/pubmed/29774061 http://dx.doi.org/10.1177/1758835918772810

Ejemplares similares

Surgical Survival Benefits With Different Metastatic Patterns for Stage IV Extrathoracic Metastatic Non-Small Cell Lung Cancer: A SEER-Based Study
por: Chao, Ce, et al.
Publicado: (2021)

The Treatment of the Earlier Stages of Senile Cataract
por: Smith, Henry
Publicado: (1914)

The Prevention of the Earlier Stages of Dental Caries
por: Colyer, Stanley
Publicado: (1911)

Value of chemotherapy post immunotherapy in stage IV non-small cell lung cancer (NSCLC)
por: Assi, Hazem I., et al.
Publicado: (2023)

Combining stereotactic body radiotherapy with immunotherapy in stage IV non-small cell lung cancer
por: Liu, Xiaoli, et al.
Publicado: (2023)

Immune checkpoint inhibitors for every patient with non-small cell lung cancer? Update on immunotherapy in patients with lung cancer
por: Vansteenkiste, Johan F
Publicado: (2018)

Patterns of care for older patients with stage IV non‐small cell lung cancer in the immunotherapy era
por: Kehl, Kenneth L., et al.
Publicado: (2020)

Personal and clinical characteristics associated with immunotherapy effectiveness in stage IV non-small cell lung cancer
por: Patel, Krishna H., et al.
Publicado: (2023)

Impact of Liver Metastasis on First-Line Immunotherapy in Stage IV Non-Small Cell Lung Cancer
por: Komiya, Takefumi, et al.
Publicado: (2023)

The Combination of Seven Preoperative Markers for Predicting Patients with Gastric Cancer to Be Either Stage IV or Non-Stage IV
por: Ge, Wei, et al.
Publicado: (2018)

The value of immunotherapy for survivors of stage IV non-small cell lung cancer: patient perspectives on quality of life
por: Park, Rebekah, et al.
Publicado: (2020)

The earlier the better? Apalutamide for non-metastatic castration resistant prostate cancer
por: De Santis, Maria, et al.
Publicado: (2019)

Immunotherapy in lung cancer
por: Vansteenkiste, Johan F
Publicado: (2018)

Surgery for stage IV non-small cell lung cancer?
por: Puig, Carlos A., et al.
Publicado: (2020)

Frequency of Hepatic Metastatic Disease in Patients with Stage IV Breast Cancer Is Similar for Steatotic and Non-Steatotic Livers
por: Haq, Adeel, et al.
Publicado: (2023)

Overall Survival Among Patients With De Novo Stage IV Metastatic and Distant Metastatic Recurrent Non–Small Cell Lung Cancer
por: Su, Chloe C., et al.
Publicado: (2023)

Role of Immunotherapy in Stage IV Large Cell Neuroendocrine Carcinoma of the Lung
por: Komiya, Takefumi, et al.
Publicado: (2021)

Platelet-to-lymphocyte and neutrophil-to-lymphocyte ratios are associated with the efficacy of immunotherapy in stage III/IV non-small cell lung cancer
por: Lu, Xiaojuan, et al.
Publicado: (2022)

RNA-sequencing in non-small cell lung cancer shows gene downregulation of therapeutic targets in tumor tissue compared to non-malignant lung tissue
por: Reynders, Kobe, et al.
Publicado: (2018)

Flexible dosing with Darbepoetin alfa for the treatment of chemotherapy-induced anemia
por: Wauters, Isabelle, et al.
Publicado: (2006)

Nivolumab for NSCLC in Japanese patients: similar benefits, but beware of pneumonitis
por: Vansteenkiste, Johan
Publicado: (2017)

The earlier, the better? A review of neoadjuvant immunotherapy in resectable non‐small‐cell lung cancer
por: Li, Fajiu, et al.
Publicado: (2022)

Immune phenotype of patients with stage IV metastatic inflammatory breast cancer
por: Fernandez, Sandra V., et al.
Publicado: (2020)

Immunotherapy around the Clock: Impact of Infusion Timing on Stage IV Melanoma Outcomes
por: Gonçalves, Lisa, et al.
Publicado: (2023)

Comparison of outcomes in patients with stage III versus limited stage IV non-small cell lung cancer
por: Cheruvu, Praveena, et al.
Publicado: (2011)

Abemaciclib in Combination With Pembrolizumab for Stage IV KRAS-Mutant or Squamous NSCLC: A Phase 1b Study
por: Pujol, Jean-Louis, et al.
Publicado: (2021)

Real-world outcomes versus clinical trial results of immunotherapy in stage IV non-small cell lung cancer (NSCLC) in the Netherlands
por: Cramer-van der Welle, Christine M., et al.
Publicado: (2021)

Anæsthetic Leprosy; with Especial Reference to Its Diagnosis and Treatment in the Earlier Stages
Publicado: (1867)

Anæsthetic Leprosy; with Especial Reference to Its Diagnosis and Treatment in the Earlier Stages
Publicado: (1867)

Anæsthetic Leprosy; with Especial Reference to Its Diagnosis and Treatment in the Earlier Stages
Publicado: (1867)

Mathematical modelling of earlier stages of COVID-19 transmission dynamics in Ghana
por: Acheampong, Edward, et al.
Publicado: (2022)

Trial on Refinement of Early stage non-small cell lung cancer. Adjuvant chemotherapy with pemetrexed and cisplatin versus vinorelbine and cisplatin: The TREAT protocol
por: Kreuter, Michael, et al.
Publicado: (2007)

Stage IV Non-small Cell Lung Cancer Presenting as Supraventricular Tachycardia
por: Amin, Hina, et al.
Publicado: (2019)

Metastatic Pattern Discriminates Survival Benefit of Type of Surgery in Patients With De Novo Stage IV Breast Cancer Based on SEER Database
por: Li, Kunlong, et al.
Publicado: (2021)

Long-term benefit of immunotherapy in metastatic non-small cell lung cancer: the tale of the tail
por: Cali Daylan, Ayse Ece, et al.
Publicado: (2023)

Nonregional Lymph Nodes as the Only Metastatic Site in Stage IV Esophageal Cancer
por: Zhan, Peter L., et al.
Publicado: (2022)

Stage III deficient mismatch repair colon patients get greater benefit from earlier starting oxaliplatin-based chemotherapy regimen
por: Zhan, Yixiang, et al.
Publicado: (2023)

Primary Tumor Resection in Stage IV Breast Cancer: Consistent Benefit, or Consistent Bias?
por: Khan, Seema A.
Publicado: (2007)

Efficacy of HBV Vaccination in Various Stages of Chronic Kidney Disease: Is Earlier Better?
por: Hashemi, Behnam, et al.
Publicado: (2011)

Corticosteroid-induced Osteonecrosis of the Femoral Head: Detection, Diagnosis, and Treatment in Earlier Stages
por: Liu, Li-Hua, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_10efcqhmqc4gsl6fitupup7g3p